Bernstein Upgrades J&J (JNJ) to Outperform; Sees Pharma Pipeline Adding $6B in Sales by 2015
Tweet Send to a Friend
Bernstein's Derrick Sung upgraded shares of Johnson & Johnson (NYSE: JNJ) from Market Perform to Outperform Wednesday morning. The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE